Oncolytics Biotech Inc. (ONCY)
Oncolytics Biotech Statistics
Share Statistics
Oncolytics Biotech has 77.07M shares outstanding. The number of shares has increased by 2.19% in one year.
| Shares Outstanding | 77.07M |
| Shares Change (YoY) | 2.19% |
| Shares Change (QoQ) | 0.11% |
| Owned by Institutions (%) | 1.57% |
| Shares Floating | 75.69M |
| Failed to Deliver (FTD) Shares | 100 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 2.81M, so 3.65% of the outstanding shares have been sold short.
| Short Interest | 2.81M |
| Short % of Shares Out | 3.65% |
| Short % of Float | 3.7% |
| Short Ratio (days to cover) | 3.51 |
Valuation Ratios
The PE ratio is -4.26 and the forward PE ratio is -1.55. Oncolytics Biotech's PEG ratio is 0.92.
| PE Ratio | -4.26 |
| Forward PE | -1.55 |
| PS Ratio | 0 |
| Forward PS | 0.2 |
| PB Ratio | 4.29 |
| P/FCF Ratio | -4.15 |
| PEG Ratio | 0.92 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Oncolytics Biotech Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.01, with a Debt / Equity ratio of 0.02.
| Current Ratio | 9.01 |
| Quick Ratio | 9.01 |
| Debt / Equity | 0.02 |
| Total Debt / Capitalization | 1.51 |
| Cash Flow / Debt | -67.25 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -1.01% and return on capital (ROIC) is -121.17%.
| Return on Equity (ROE) | -1.01% |
| Return on Assets (ROA) | -0.71% |
| Return on Capital (ROIC) | -121.17% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-956,965.52 |
| Employee Count | 29 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 97K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -41.96% in the last 52 weeks. The beta is 1.54, so Oncolytics Biotech's price volatility has been higher than the market average.
| Beta | 1.54 |
| 52-Week Price Change | -41.96% |
| 50-Day Moving Average | 0.81 |
| 200-Day Moving Average | 0.98 |
| Relative Strength Index (RSI) | 32.75 |
| Average Volume (20 Days) | 1.22M |
Income Statement
| Revenue | n/a |
| Gross Profit | -403K |
| Operating Income | -33.79M |
| Net Income | -27.75M |
| EBITDA | -33.71M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.41 |
Balance Sheet
The company has 34.91M in cash and 423K in debt, giving a net cash position of 34.49M.
| Cash & Cash Equivalents | 34.91M |
| Total Debt | 423K |
| Net Cash | 34.49M |
| Retained Earnings | -446M |
| Total Assets | 24.26M |
| Working Capital | 15.25M |
Cash Flow
In the last 12 months, operating cash flow was -28.45M and capital expenditures -8K, giving a free cash flow of -28.46M.
| Operating Cash Flow | -28.45M |
| Capital Expenditures | -8K |
| Free Cash Flow | -28.46M |
| FCF Per Share | -0.42 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ONCY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -63.08% |
| FCF Yield | -56.44% |
Analyst Forecast
The average price target for ONCY is $4, which is 515.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $4 |
| Price Target Difference | 515.4% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on May 25, 2018. It was a backward split with a ratio of 2:19.
| Last Split Date | May 25, 2018 |
| Split Type | backward |
| Split Ratio | 2:19 |
Scores
| Altman Z-Score | -29.03 |
| Piotroski F-Score | 1 |